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Abstract
Serum haptoglobin (Hp) and haptoglobin matrix metalloproteinase 9 complexes (Hp-MMP 9) have been
identified as biomarkers with diagnostic potential in cattle with conditions resulting in an acute inflammatory
response. The purpose of this study was to evaluate potential diagnostic applications of serum Hp and Hp-
MMP 9 concentrations in calves with BRD and establish a timeline for their detection in calves
experimentally challenged with Bibersteinia trehalosi and Mannheimia haemolytica. Thirty-five cross bred dairy
calves were inoculated via tracheal catheterization with either a PCR confirmed leukotoxin negative B.
trehalosi isolate, a PCR confirmed leukotoxin positive B. trehalosi isolate, a Mannheimia haemolyticaisolate, a
combination of leukotoxin negative B. trehalosi and M. haemolytica, or a negative control. Serum samples were
collected throughout the study. Calves were euthanized and necropsy performed on day 10 post inoculation.
M. haemolytica inoculated calves had increased lung involvement. Serum Hp and Hp- MMP 9 concentrations
were elevated compared to the other treatment groups. Increases in serum Hp and Hp-MMP 9 concentrations
for the M. haemolyticagroup were significantly different from other study groups on day 7 of the study. B.
trehalosi inoculated calves did not have increased lung involvement compared to control calves, but the
leukotoxin positive B. trehalosi group demonstrated increased serum Hp-MMP 9 concentrations from day 3 to
the end of the study compared to the pre-inoculation concentrations. Serum Hp-MMP 9 concentration is a
useful diagnostic tool for detecting early pulmonary inflammation in calves challenged with B. trehalosi and M.
haemolytica. Serum Hp-MMP 9 may also be a useful tool in detecting subclinical pulmonary inflammation in
challenged calves.
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Serum concentrations of haptoglobin and
haptoglobin-matrix metalloproteinase 9
(Hp-MMP 9) complexes of bovine calves in a
bacterial respiratory challenge model
Christy J Hanthorn1, Grant A Dewell1*, Renee D Dewell1,2, Vickie L Cooper1, Chong Wang1,4, Paul J Plummer1,3
and Jeffrey Lakritz5
Abstract
Background: Serum haptoglobin (Hp) and haptoglobin matrix metalloproteinase 9 complexes (Hp-MMP 9) have
been identified as biomarkers with diagnostic potential in cattle with conditions resulting in an acute inflammatory
response. The purpose of this study was to evaluate potential diagnostic applications of serum Hp and Hp-MMP 9
concentrations in calves with BRD and establish a timeline for their detection in calves experimentally challenged
with Bibersteinia trehalosi and Mannheimia haemolytica. Thirty-five cross bred dairy calves were inoculated via tracheal
catheterization with either a PCR confirmed leukotoxin negative B. trehalosi isolate, a PCR confirmed leukotoxin positive
B. trehalosi isolate, a Mannheimia haemolytica isolate, a combination of leukotoxin negative B. trehalosi and M. haemolytica,
or a negative control. Serum samples were collected throughout the study. Calves were euthanized and necropsy
performed on day 10 post inoculation.
Results: M. haemolytica inoculated calves had increased lung involvement. Serum Hp and Hp- MMP 9 concentrations
were elevated compared to the other treatment groups. Increases in serum Hp and Hp-MMP 9 concentrations for the
M. haemolytica group were significantly different from other study groups on day 7 of the study. B. trehalosi inoculated
calves did not have increased lung involvement compared to control calves, but the leukotoxin positive B. trehalosi
group demonstrated increased serum Hp-MMP 9 concentrations from day 3 to the end of the study compared to the
pre-inoculation concentrations.
Conclusion: Serum Hp-MMP 9 concentration is a useful diagnostic tool for detecting early pulmonary inflammation in
calves challenged with B. trehalosi and M. haemolytica. Serum Hp-MMP 9 may also be a useful tool in detecting
subclinical pulmonary inflammation in challenged calves.
Keywords: Hp-MMP 9, Haptoglobin, MMP 9, Bovine Respiratory Disease, Pneumonia, Calf
Background
Bovine respiratory disease (BRD) has been shown to
affect various biomarkers in cattle [1-7]. Two biomarkers
that have been identified for diagnostic potential are serum
haptoglobin (Hp), matrix metalloproteinase 9 (MMP 9),
and the complexes that they are able to form (Hp-MMP 9)
[1,6-9].
Free Hp is an alpha - 2 globulin that is primarily
synthesized in the liver [3]. Free Hp’s primary function
is to bind to free hemoglobin in the blood. By scaven-
ging the free hemoglobin, Hp helps to prevent oxida-
tive tissue damage and conserve iron by returning the
heme residue to the host’s metabolic process. This
scavenging mechanism also serves to decrease the risk
of free hemoglobin being utilized for bacterial patho-
gen growth [7,8].
MMP 9 is a collagenase belonging to the gelatinase B
group [5]. The gelatinase B group is a family of MMP’s
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that are zinc dependent proteinases capable of degrading
at least one component of the extracellular matrix or
basement membrane. This capability assists in the mi-
gration of white blood cells, mostly neutrophils, from
the blood to the site of inflammation [4]. MMP 9 is
stored in tertiary granules within the bovine neutrophils
and is released when neutrophil degranulation is induced
by either chemical or microbial stimuli [1,5,10,11]. After
release, MMP 9 is able to cleave interleukin 8, if present
in the microenvironment into active interleukin 8. This
creates a positive feedback loop for neutrophil migra-
tion [10]. While only neutrophils have been demon-
strated to store MMP 9 for immediate release [8], other
cells such as alveolar macrophages can be induced to
produce MMP 9 [5,12].
Free Hp and MMP 9 are secreted by multiple cellular
sources in response to a variety of challenges; Hp-MMP
9 complexes have been shown to form exclusively in
neutrophils [1]. These complexes are stored until neu-
trophil degranulation at which time they are released
[1,6,8]. Hp has been demonstrated to have a high diag-
nostic sensitivity for detecting infectious or inflamma-
tory conditions. Due to its poor specificity, it cannot be
used as the primary diagnostic test for any one condi-
tion. Free Hp is also poor at differentiating between
acute and chronic inflammation [1,7]. Free MMP 9 is
more specific to acute inflammation, but it is not spe-
cific enough to differentiate between healthy and dis-
eased cattle [1,4]. Hp-MMP 9 complexes are capable of
differentiating between acute and chronic inflammation
as their release from neutrophils is associated with acute
inflammatory responses [1,8].
Various biomarkers potentially associated with BRD have
been studied. In previous studies Hp was demonstrated to
increase after calves were exposed to Mannheimia haemo-
lytica via intra-tracheal inoculation with the earliest detec-
tion occurring at 24 hours, and peak concentrations
occurring at 3 days post inoculation [6,7]. In another chal-
lenge study, increases in serum Hp concentrations in calves
infected with BVDV were not detected until 7–9 days post
infection [7]. Serum concentrations of Hp-MMP 9 have
not been evaluated in a BRD challenge study. The purpose
of this study was two-fold: to evaluate the diagnostic appli-
cations of serum Hp-MMP 9 concentrations in calves with
BRD and to establish a timeline for their detection in calves
undergoing experimental challenge with Bibersteinia treha-
losi and Mannheimia haemolytica.
Methods
Prior to initiating the study, the protocol was approved
by the Iowa State University Institutional Animal Care
and Use Committee (IACUC 8-11-7187-B) and the
Institutional Biosafety Committee (IBC#11-D-0017-A).
This study is a hypothesis generating study representing
a secondary use of calves enrolled in a challenge study
designed to evaluate the pathogenicity of Bibersteinia
trehalosi in respiratory disease among bovine calves
[13]. The rationale for the secondary use of these calves
to meet additional objectives is consistent with using
the 3R principles to maximize information obtained
from animal research [14].
Individually housed calves were inoculated via tracheal
catheterization with of either a PCR (lktA) confirmed
leukotoxin negative B. trehalosi isolate (8 calves), a PCR
confirmed leukotoxin positive B. trehalosi isolate (8 calves),
a Mannheimia haemolytica isolate (7 calves), a combin-
ation of leukotoxin negative B. trehalosi and M. haemoly-
tica (8 calves), or a negative control (4 calves) as previously
described [13]. The B. trehalosi isolates were field strains
obtained from diagnostic submissions and the M. haemoly-
tica isolate was a proprietary leukotoxin positive isolate.
Calves were inoculated with 20 ml of a Brain Heart Infu-
sion broth containing approximately 2.5 × 109 CFU of bac-
terial per milliliter.
Blood samples were collected from each calf via jugu-
lar venipuncture on Days 1 (pre-inoculation), 3, 5, 7, 9,
and 10 (immediately prior to euthanasia). Blood samples
were centrifuged at 4000 rpm for 15 minutes. Following
centrifugation, samples were placed on ice before being
transferred, using a transfer pipette, to an appropriately
labeled cryovial. Boxes containing cryovials were placed
immediately in an ultra-low freezer and stored at - 70°C
until being shipped to The Ohio State University on dry
ice for analysis.
All surviving calves were euthanized on day 10 of the
study, necropsied, and evaluated for percent abnormal
lung involvement as previously described [13].
Serum Haptoglobin-Matrix metalloproteinase 9 (Hp-MMP 9)
ELISA assay
Bovine Hp-MMP 9 complexes were determined as de-
scribed previously [1,6,15]. All serum samples were di-
luted 1:5 with sample diluent (TBS +1% Bovine serum
albumin +0.05% Tween 20). After blocking the wells
(4°C for 120 minutes), known concentrations of Hp-
MMP 9 (serum, pre-characterized and shown to con-
tain ~912.6 ng/mL Hp-MMP 9) and the challenged calf
serum samples were added to wells. Serum from
healthy cows was used as a negative control.
Serum total haptoglobin ELISA assay
Serum Hp concentrations were determined as described
(Bovine haptoglobin 96-well ELISA. Life Diagnostics,
West Chester, PA 19380) using commercial Bovine
haptoglobin ELISA test kits, according to manufacturer’s
instructions. Standard curves were prepared using purified
bovine haptoglobin standard (2.5 μg/mL) included with
the kit at a concentration range from 7.8 – 250 ng/mL.
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Serum samples were diluted according to the kit in-
structions (1:2,000 dilution) and were run in duplicate.
Controls included were normal bovine serum, 5% BSA
in TBS and blank wells. Linear regression of the Hp
calibrator concentration versus absorbance was used to
determine the equation for the line. The slope and
intercept of this line was used to calculate the concentra-
tion of serum total Hp in the unknown animal samples.
These concentrations were corrected for the dilution fac-
tor (× 2,000) and the concentrations reported in μg/mL.
Statistical analysis
Hp- MMP 9 and Hp were analyzed by repeated mea-
sures analysis of variance (ANOVA), with treatment,
time, and their interaction as fixed effects and animal as
subject of repeated measures. Lung involvement was an-
alyzed by analysis of variance model, with treatment as
explanatory variable. Correlations were calculated among
the values of lung involvement, Hp, and Hp-MMP 9 for
both Hp and Hp-MMP 9 serum concentrations as both
ranked and absolute values prior to the challenge as well
as averaged over the time of the study. SAS® Version 9.2
(SAS® Institute Inc., Cary, NC, USA) was used in analyses.
A p-value <0.05 was considered significant.
Results and discussion
Lung involvement
Prior to inoculation all calves appeared clinically normal.
Pasteurella multocida was isolated from pharyngeal
swab samples from 34 of 35 calves. M. haemolytica was
isolated from 8 of 35 calves. M. haemolytica positive
pharyngeal swab calves were spread across all five treat-
ment groups (1/4 in control group, 1/8 in leukotoxin
negative B. trehalosi group, 2/8 in leukotoxin positive B.
trehalosi group, 1/7 in M. haemolytica group, 3/8 in leu-
kotoxin negative B. trehalosi and M. haemolytica com-
bination group).
Six of the 35 enrolled calves were euthanized prior
to day 9 of the study. Three calves (3/7) from the M.
haemolytica group (days 2, 3 and 3) and three calves
(3/8) from the leukotoxin negative B. trehalosi and M.
haemolytica combination treatment (days 3, 5 and 8)
were euthanized according to protocol because of a
clinical assessment of moribund.
The mean estimated percent lung involvement was
highest for the M. haemolytica group (49%). The mixed
infection group of leukotoxin negative B. trehalosi and
M. haemolytica had a mean lung involvement of 26%.
The leukotoxin positive B. trehalosi had a mean lung in-
volvement of 18% while the leukotoxin negative B. treha-
losi mean lung involvement was estimated to be 13%. The
control group had a mean lung involvement estimate
of 13%. There was evidence of a statistically significant
(p = 0.018) difference for mean percent total lung
involvement between the M. haemolytica group and
the leukotoxin negative B. trehalosi group. There were
no significant differences between the other treatment
groups. Even though the control group had a lower
mean percent lung involvement than the leukotoxin
negative B. trehalosi treatment group, the low number
(4 calves) of study subjects in the control group did
not have sufficient power to make it significantly dif-
ferent from the M. haemolytica treatment group. The
mean and median values were similar in all treatment
groups except the mixed infection group. This group had
a high amount of variability within it as evidenced by a
mean percent lung involvement of 26% and a median per-
cent lung involvement of 5%. The high variability made
drawing conclusions difficult in this group (Figure 1).
Free Hp
Other studies have found that serum Hp is nearly un-
detectable in healthy cattle [8]. Concentrations up to
about 200 μg/mL are considered acceptable for healthy
animals [2,7,9,16]. Concentrations between about 200
and 400 μg/mL are associated with mild inflammation
and concentrations greater than about 400 μg/mL sug-
gest severe inflammation [7]. Serum Hp concentration
does not differ with age or sex in cattle [2,7,9].
In this study, 11 calves (2/4 in the control group, 2/8
in the leukotoxin negative B. trehalosi group, 4/8 in the
leukotoxin positive B. trehalosi group, 1/7 in the M.
haemolytica group, and 2/8 in the leukotoxin negative
B. trehalosi and M. haemolytica combination group)
had serum Hp concentrations greater than 200 μg/mL
prior to inoculation. Two of the calves had low serum
concentrations of Hp-MMP 9 indicating the presence
of chronic inflammation. M. haemolytica was cultured
from the pharyngeal swabs of both calves. Nine of the
calves with high serum concentrations of Hp also had
high serum concentrations of Hp-MMP 9 indicating
the presence of chronic inflammation which was associ-
ated with an acute inflammatory event. Three of these
calves were culture positive for M. haemolytica from
pharyngeal swabs. Nineteen calves had no detectible
serum Hp prior to inoculation.
The interaction between treatment group and bleed-
ing date was a statistically significant effect (p = 0.01).
The mean serum Hp concentration for the leukotoxin
positive B. trehalosi treatment group was significantly
(p = 0.008) different from the other treatment groups
for the pre-inoculation bleeding date, indicating that
more calves with evidence of chronic inflammation
prior to commencement of the study were randomly
assigned to this treatment group. On the fourth and
sixth bleeding dates (days 7 and 10) there was a signifi-
cant (p < 0.05) difference in the mean Hp concentration
between the M. haemolytica treatment group and the
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Figure 1 Distribution of lung involvement. Distribution of percent lung involvement by treatment group. Treatment group 0: Negative control
group, Treatment group 1: leukotoxin negative B. trehalosi group, Treatment group 2: leukotoxin positive B. trehalosi group, Treatment group 3: M.
haemolytica group, Treatment group 4: Combination of leukotoxin negative B. trehalosi and M. haemolytica group. Means with different letters are
significantly different (p < 0.05). Diamonds represent the group mean. Boxes represent the middle two quartiles of individual values, divided by
the center line which represents the median. Bars adjacent to the boxes represent the outer two quartiles of individual values.
Figure 2 Means of serum HP concentration for treatment group by date. Serum Hp concentration in micrograms/mL over time by
treatment group. Treatment group 0: Negative control group, Treatment group 1: leukotoxin negative B. trehalosi group, Treatment group 2: leukotoxin
positive B. trehalosi group, Treatment group 3: M. haemolytica group, Treatment group 4: Combination of leukotoxin negative B. trehalosi and
M. haemolytica group. Circles above trend lines indicate significant differences from other treatment groups. Triangles below trend lines
indicate significant differences from prior bleeding dates.
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leukotoxin negative B. trehalosi treatment group and
the leukotoxin negative B. trehalosi and M. haemolytica
combination group. The M. haemolytica treatment
group demonstrated significant elevations in serum Hp
concentrations from the first two bleeding dates to the
third bleeding date (day 5) (p = 0.02). The elevation in
serum Hp concentration remained significant (p < 0.02)
throughout the study. This finding is in agreement with
other studies that have demonstrated an increase in
serum Hp after M. haemolytica infection [4,6]. Concen-
trations in this study peaked on day 7 rather than day 3
as previously reported. A decrease in the serum Hp
concentration for the mixed infection group can be ob-
served between the second and third bleeding dates
(days 3 and 5). This observation supports findings by
Dassanayake et al. suggesting that B. trehalosi is capable
of inhibiting the growth of M. haemolytica in vivo [17]. In
this study the difference in serum Hp concentration is not
significantly different from the other treatment groups.
Two calves from this treatment group were euthanized
before the third bleeding time point. The smaller treat-
ment group likely did not have enough power for a statis-
tical difference to be observed (Figure 2).
Hp-MMP 9
The mean serum Hp-MMP 9 concentration for all treat-
ment groups prior to inoculation was 104 ng/mL, with a
minimum value of 0 ng/mL, a maximum value of
752.2 ng/mL, and a median value of 4.15 ng/mL. Little
to no Hp-MMP 9 should be detectible in the serum of
healthy calves [6]. Sixteen calves had no detectible serum
Hp-MMP 9 concentration prior to inoculation. For this
study a serum concentration greater than 20 ng/mL was
considered high. Thirteen calves had high serum Hp-
MMP 9 concentrations prior to inoculation. Four of the
thirteen calves had low serum concentrations of Hp,
suggesting the presence of a mild acute inflammatory
process. None of these 4 calves were culture positive for
M. haemolytica from the pharyngeal swabs. Nine of the
thirteen calves had high serum concentrations of Hp
and were discussed previously.
Treatment group, bleeding date, and their interaction
were all significant (p < 0.01) effects. On the fourth
bleeding date (day 7) the mean serum Hp-MMP 9 con-
centration for the M. haemolytica group became sig-
nificantly different from the negative control, the
leukotoxin negative B. trehalosi, and the leukotoxin
negative B. trehalosi and M. haemolytica combination
groups (p = 0.01, p = 0.009, and p = 0.004 respectively).
This difference continued throughout the study. On the
fifth bleeding date (day 9) the mean serum Hp-MMP 9
concentration for the M. haemolytica group became
significantly different from the leukotoxin positive B.
trehalosi group (p = 0.006) and remained different
throughout the rest of the study. The M. haemolytica
group demonstrated significant elevations in serum
Hp-MMP 9 concentrations from the first three bleeding
dates to the last three bleeding dates (p < 0.02). The leu-
kotoxin positive B. trehalosi treatment group demonstrated
a small but significant (p < 0.004) elevation in serum Hp-
MMP 9 concentrations from the pre-inoculation bleeding
date to the second bleeding date (day 3) that continued
throughout the study (Figure 3). This finding is consistent
with other studies that have demonstrated the rapid re-
cruitment and accumulation of neutrophils at the onset of
BRD [6] as well as the action of leukotoxins to stimulate
the active degranulation of bovine neutrophils [5].
Correlations
There was statistically significant (p < 0.0001) evidence of
a strong (r = 0.7) correlation between Hp and Hp-MMP 9
serum concentrations as both ranked and absolute values
prior to inoculation. Evidence of a relationship remained
statistically significant over time (p < 0.0001), but the
strength of the relationship varied depending on if a Pearson
(absolute values) or Spearman (ranked data) correlation
coefficient was calculated. The Pearson correlation co-
efficient was r = 0.63; whereas, the Spearman correl-
ation coefficient was r = 0.79. This strong relationship was
expected since both substances have been established as
biomarkers for inflammation and the test for free Hp
measures Hp-MMP 9 contribution also.
There was statistically significant evidence (p < 0.05) of
a moderate correlation (r = 0.44 and r = 0.35) that be-
came stronger over time (r = 0.67 and r = 0.48) between
Hp-MMP 9 and percent lung involvement for both
ranked and absolute values respectively. There was statisti-
cally significant evidence (p = 0.04) of a moderate (r = 0.35)
correlation between free Hp and percent lung involvement
for ranked, but not absolute values prior to inoculation.
This correlation became stronger (r = 0.54, p = 0.0008)
when values were averaged over the time of the study. The
correlation between free Hp and percent lung involvement
for absolute data was also statistically significant when av-
eraged over time (r = 0.41, p = 0.015).
This correlation data indicates that Hp-MMP 9 serum
concentrations may be a good ante-mortem diagnostic in-
dicator of lung damage that is found at the time of the
calf ’s death. This data also supports the conclusion from
other studies that Hp-MMP 9 serum concentration is a
better diagnostic test for lung damage than free Hp serum
concentration [1]. Future studies should be conducted to
determine reference ranges of serum Hp-MMP 9 for dif-
ferent levels of disease severity.
Conclusion
All study calves appeared to be clinically normal prior to
inoculation in this study. Culture results of pharyngeal
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swabs taken from calves prior to inoculation showed
that all but one calf was positive for P. multocida. The
presence of this bacterium did not appear to have an
impact on pre-inoculation values of serum Hp or Hp-
MMP 9 since many of the calves had serum concentra-
tions of these two biomarkers that were within limits
considered acceptable for healthy animals [2,7,9,16].
The pharyngeal swabs for 8 calves were culture positive
for M. haemolytica prior to inoculation. This finding
could have potentially affected the development of lung
lesions as well as increases in serum Hp and Hp-MMP
9 concentrations in calves that were members of treat-
ment groups other than the M. haemolytica group. The
effect was not large enough to preclude seeing statisti-
cally significant results from the challenge in the M.
haemolytica group. The development of a rapid, inex-
pensive test for serum Hp-MMP 9 concentrations could
have clinical applications as a screening test for subject
enrollment in BRD studies. Subjects with elevated serum
concentrations could be excluded from participation.
Significant differences were observed between the M.
haemolytica group and the other treatment groups in
percent total lung involvement, serum Hp, and serum
Hp-MMP 9 concentrations. The difference in percent
total lung involvement demonstrates that the inoculation
technique was appropriate for this challenge model. The
increase in serum Hp and Hp-MMP 9 concentrations at
day 7 are consistent with other reports of these two
biomarkers having diagnostic potential with respect to
BRD. Results suggest a different, slightly later, timeframe
for using them as diagnostic tools.
No significant difference was observed between the
leukotoxin positive B. trehalosi treatment group and the
negative control, leukotoxin negative B. trehalosi, and
combination of leukotoxin negative B. trehalosi and M.
haemolytica groups with respect to percentage of total
lung involvement or serum Hp concentrations. A small
but significant increase was noted in the serum Hp-
MMP 9 concentrations of the leukotoxin positive B. tre-
halosi treatment group from day 1 to day 3, indicating
that serum Hp-MMP 9 concentrations may be a more
sensitive test for pulmonary inflammation than visible
lung damage or serum Hp concentrations. This finding
also provides evidence that the leukotoxin positive strain
of B. trehalosi induced more neutrophil degranulation
leading to a higher release of Hp-MMP 9 complexes
than the leukotoxin negative strain of B. trehalosi. In this
study the earlier rise in the serum Hp-MMP 9 concen-
tration for the leukotoxin positive B. trehalosi treatment
group than for the M. haemolytica treatment group may
indicate that bovine neutrophils respond faster to a B.
trehalosi infection than to a M. haemolytica infection.
The stronger significant correlation between serum
Hp-MMP 9 concentration and percent lung involvement
than between serum Hp concentration and percent lung
involvement support the conclusions of other studies
Figure 3 Means of serum Hp-MMP 9 concentration for treatment group by date. Serum Hp-MMP 9 concentration in nanograms/mL over
time by treatment group. Treatment group 0: Negative control group, Treatment group 1: leukotoxin negative B. trehalosi group, Treatment group 2:
leukotoxin positive B. trehalosi group, Treatment group 3: M. haemolytica group, Treatment group 4: Combination of leukotoxin negative B. trehalosi
and M. haemolytica group. Circles above trend lines indicate significant differences from other treatment groups. Triangles below trend lines indicate
significant differences from prior bleeding dates.
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that serum Hp-MMP 9 concentrations can be an effect-
ive tool for early diagnosis of BRD [6] and that it is a
better diagnostic tool for acute inflammation than serum
Hp [1]. Future studies to determine a reference range for
serum Hp-MMP 9 concentration and to develop a rapid,
inexpensive test would help to make serum Hp-MMP 9
concentration a clinically useful diagnostic tool.
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